Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
2.
Brain Behav Immun ; 17(6): 442-52, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14583236

RESUMEN

Sympathetic activation occurs rapidly following intracerebroventricular (icv) injection of prostaglandin E2(PGE2). This study examined whether neuropeptides mediate PGE2-induced sympathetic nerve activation in urethane/chloralose-anesthetized Sprague-Dawley rats. Animals were pretreated (20.0 microg, icv) with the following receptor antagonists; CRF ([D-Phe12,Nle21,38,Calpha-MeLeu37]CRF12-41), AVP-V1 (Des-Gly-[Phaa1, D-Tyr(Et)2,Lys6,Arg8]-vasopressin), or OT (OT+V1, [d(CH2)5,Tyr(Me)2,Orn8]-vasotocin) followed 20 min later by PGE2 (2.0 microg, icv). Pretreatment with the CRF antagonist attenuated the increase in renal nerve activity induced by PGE2 when measured 10 and 30 min post-injection. PGE2-induced renal nerve activity was also inhibited at both time points by the AVP antagonist and, to a similar extent, the OT antagonist. The AVP antagonist did not effect splenic nerve responses to PGE2 whereas the CRF antagonist produced an incomplete and transient reduction in PGE2-induced activation of the splenic nerve. However, the OT antagonist completely blocked the activation of the splenic nerve after central injection of PGE2. ICV injections of AVP and OT produced immediate changes in splenic and renal nerve activity whereas CRF failed to alter the activity of either nerve in anesthetized or conscious animals. Thus, PGE2 acts through neuropeptide-specific pathways to initiate sympathetic outflow and OT is a specific component of the sympathetic pathway innervating the spleen.


Asunto(s)
Dinoprostona/fisiología , Riñón/inervación , Neuroinmunomodulación/fisiología , Bazo/inervación , Sistema Nervioso Simpático/fisiología , Animales , Antagonistas de los Receptores de Hormonas Antidiuréticas , Encéfalo/fisiología , Dinoprostona/administración & dosificación , Antagonistas de Hormonas/farmacología , Inyecciones Intraventriculares , Masculino , Neuroinmunomodulación/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Receptores de Hormona Liberadora de Corticotropina/antagonistas & inhibidores , Receptores de Oxitocina/antagonistas & inhibidores , Sistema Nervioso Simpático/efectos de los fármacos
3.
J Biol Chem ; 278(26): 23915-21, 2003 Jun 27.
Artículo en Inglés | MEDLINE | ID: mdl-12690108

RESUMEN

CD47 is a surface receptor that induces either coactivation or apoptosis in lymphocytes, depending on the ligand(s) bound. Interestingly, the apoptotic pathway is independent of caspase activation and cytochrome c release and is accompanied by early mitochondrial dysfunction with suppression of mitochondrial membrane potential (Deltapsim). Using CD47 as bait in a yeast two-hybrid system, we identified the Bcl-2 homology 3 (BH3)-only protein 19 kDa interacting protein-3 (BNIP3), a pro-apoptotic member of the Bcl-2 family, as a novel partner. Interaction between CD47 and the BH3-only protein was confirmed by immunoprecipitation analysis, and CD47-induced apoptosis was inhibited by attenuating BNIP3 expression with antisense oligonucleotides. Finally, we showed that the C-terminal domain of thrombospondin-1 (TSP-1), but not signal-regulatory protein (SIRPalpha1), is the ligand for CD47 involved in inducing cell death. Immunofluorescence analysis of CD47 and BNIP3 revealed a partial colocalization of both molecules under basal conditions. After T cell stimulation via CD47, BNIP3 translocates to the mitochondria to induce apoptosis. These results show that the BH3-dependent apoptotic pathways, previously shown to be activated by intracellular pro-apoptotic events, can also be turned on by surface receptors. This new pathway results in a fast induction of cell death resembling necrosis, which is likely to play an important role in lymphocyte regulation at inflammatory sites and/or in the vicinity of thrombosis.


Asunto(s)
Antígenos CD/fisiología , Apoptosis , Proteínas Portadoras/fisiología , Proteínas de la Membrana/fisiología , Proteínas Proto-Oncogénicas , Linfocitos T/citología , Proteínas Supresoras de Tumor , Antígeno CD47 , Humanos , Células Jurkat , Proteínas de la Membrana/metabolismo , Mitocondrias/química , Mitocondrias/patología , Transporte de Proteínas , Transducción de Señal , Solubilidad , Linfocitos T/metabolismo , Linfocitos T/ultraestructura , Trombospondina 1/química , Trombospondina 1/metabolismo , Técnicas del Sistema de Dos Híbridos
4.
Brain Behav Immun ; 17(6): 482-97, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14583240

RESUMEN

Both the hypothalamic pituitary adrenal axis (HPAA) and the sympathetic nervous system (SNS) can inhibit immune function and are regarded as the primary efferent pathways for neural-immune interactions. To determine if this relationship is maintained in vivo in response to an inflammatory stimulus, rats were injected intravenously (iv) with various doses of lipopolysaccharide (LPS) and splenic cytokine mRNA and protein levels were measured at several dose and time intervals post-injection. The spleen was chosen as the target organ because both the neural and hormonal inputs to the spleen can be selectively removed by splenic nerve cut (SNC) and adrenalectomy (ADX), respectively. Data from our dose response studies established that maximum levels of splenic cytokines were induced in response to relatively low doses of LPS. Minimal changes in LPS-induced splenic cytokine levels were observed in response to ADX, SNC, or a combination of the two procedures across several doses of LPS. These results suggest that there are aspects of immune regulation that are functionally removed from these central modulatory systems and that the counter-regulatory responses induced by LPS have minimal impact on the concurrent induction of cytokines by this inflammatory stimulus. The conceptual model of neural-immune regulation as an inhibitory feedback system, at least with regards to the early activational effects induced by an inflammatory stimulus, was not supported by these studies.


Asunto(s)
Interleucina-1/metabolismo , Interleucina-6/metabolismo , Lipopolisacáridos/inmunología , Bazo/inmunología , Bazo/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Glándulas Suprarrenales/fisiología , Análisis de Varianza , Animales , Catecolaminas/sangre , Corticosterona/sangre , Relación Dosis-Respuesta a Droga , Inmunohistoquímica , Interleucina-1/genética , Interleucina-6/genética , Lipopolisacáridos/farmacología , Masculino , Neuroinmunomodulación/fisiología , ARN Mensajero/análisis , Ratas , Ratas Sprague-Dawley , Bazo/efectos de los fármacos , Bazo/inervación , Factor de Necrosis Tumoral alfa/genética
5.
Brain Behav Immun ; 18(3): 262-73, 2004 May.
Artículo en Inglés | MEDLINE | ID: mdl-15050653

RESUMEN

The mechanisms mediating the effects of stress on immune function have yet to be fully described. In vitro studies have demonstrated a role for both the sympathetic nervous system (SNS) and the hypothalamic pituitary adrenal axis (HPAA) in regulating immune responses following exposure to various stressors. The purpose of the present set of experiments was to determine the in vivo contribution of the HPAA and SNS in regulating the effects of stress on lipopolysaccharide (LPS) induced splenic cytokine production. For this, rats with combinations of sham surgeries, splenic nerve cuts (SNC), and adrenalectomies (ADX) were exposed to 15 min of 1.6 mA intermittent footshock immediately following the intravenous (i.v.) injection of 0.1 microg of LPS. Although footshock was immunosuppressive to most indices of cytokine production, neither SNC nor ADX alone blocked the effects of stress on splenic immune function. However the combination of these two manipulations significantly abrogated the immunosuppressive effects of stress on cytokine production. Adrenal demedullation of animals with a SNC demonstrated that the SNS, not the HPAA, was primarily responsible for the immunosuppressive effects of stress.


Asunto(s)
Interleucina-1/biosíntesis , Lipopolisacáridos/farmacología , Neuroinmunomodulación/efectos de los fármacos , Bazo/inmunología , Estrés Psicológico/inmunología , Sistema Nervioso Simpático/inmunología , Factor de Necrosis Tumoral alfa/biosíntesis , Adrenalectomía , Análisis de Varianza , Animales , Citocinas/efectos de los fármacos , Citocinas/inmunología , Citocinas/metabolismo , Desnervación , Relación Dosis-Respuesta a Droga , Regulación hacia Abajo , Sistema Hipotálamo-Hipofisario/efectos de los fármacos , Sistema Hipotálamo-Hipofisario/inmunología , Interleucina-1/inmunología , Interleucina-6/biosíntesis , Interleucina-6/inmunología , Masculino , Sistema Hipófiso-Suprarrenal/efectos de los fármacos , Sistema Hipófiso-Suprarrenal/inmunología , Ratas , Ratas Sprague-Dawley , Bazo/efectos de los fármacos , Bazo/inervación , Bazo/metabolismo , Sistema Nervioso Simpático/efectos de los fármacos , Sistema Nervioso Simpático/cirugía , Factor de Necrosis Tumoral alfa/efectos de los fármacos , Factor de Necrosis Tumoral alfa/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA